c-Rel anticorps (AA 1-209)
Aperçu rapide pour c-Rel anticorps (AA 1-209) (ABIN1804275)
Antigène
Voir toutes c-Rel AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- AA 1-209
-
Marque
- IHC-plus™
-
Specificité
- Human c-Rel. Predicted cross-reactivity based on amino acid sequence homology: mouse (93 % ).
-
Purification
- Immunoaffinity purified
-
Immunogène
-
Recombinant fragment corresponding to a region within amino acids 1 and 209 of c-Rel (Uniprot ID#Q04864)
Type of Immunogen: Recombinant protein
-
-
-
-
Indications d'application
- Approved: IHC, IHC-P (10 μg/mL), WB (1:500 - 1:3000)
-
Commentaires
-
Target Species of Antibody: Human
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- Lot specific
-
Buffer
- 0.1 M Tris-glycine, pH 7, 10 % Glycerol, 0.01 % Thimerosal
-
Agent conservateur
- Thimerosal (Merthiolate)
-
Précaution d'utilisation
- This product contains Thimerosal (Merthiolate): a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Conseil sur la manipulation
- Avoid repeated freezing and thawing.
-
Stock
- -20 °C
-
Stockage commentaire
- Aliquot and store at -20°C. Avoid freeze-thaw cycles.
-
-
- c-Rel (REL proto-oncogene (c-Rel))
-
Autre désignation
- REL / C-Rel
-
Sujet
-
Name/Gene ID: REL
Synonyms: REL, C-Rel, C-Rel proto-oncogene protein, I-Rel, Proto-oncogene c-Rel -
ID gène
- 5966
-
UniProt
- Q04864
Antigène
-